World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
67
Citations
22952
World Ranking
2643
National Ranking
1262

Overview

Jonathan Corren is affiliated with the University of California, Los Angeles in the United States. Their research primarily centers on medicine, with a focus on physiology, pulmonary and respiratory medicine, immunology and allergy, immunology, and surgery.

The scientist's work covers several key topics including:

  • Asthma and respiratory diseases
  • Allergic Rhinitis and Sensitization
  • IL-33, ST2, and ILC Pathways
  • Respiratory and Cough-Related Research
  • Eosinophilic Esophagitis
  • Dermatology and Skin Diseases
  • Pharmaceutical studies and practices

Jonathan Corren has published extensively, with notable recent papers including:

  • "Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma," 2021, New England Journal of Medicine
  • "Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials," 2020, Journal of Allergy and Clinical Immunology
  • "Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma," 2020, Allergy
  • "EAACI Biologicals Guidelines-Recommendations for severe asthma," 2020, Allergy
  • "Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial," 2020, The Lancet Respiratory Medicine

The scientist frequently publishes in these journals:

  • Journal of Allergy and Clinical Immunology
  • Annals of Allergy Asthma & Immunology
  • The Journal of Allergy and Clinical Immunology In Practice
  • Allergy
  • Journal of Asthma and Allergy

Jonathan Corren collaborates regularly with several co-authors, including:

  • Ian Pavord
  • Gene Colice
  • Yamo Deniz
  • Andrew Menzies-Gow
  • Thomas B. Casale

Best Publications

  • Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma

    Mario Castro;Jonathan Corren;Ian D. Pavord;Jorge Maspero

  • Lebrikizumab Treatment in Adults with Asthma

    Jonathan Corren;Robert F. Lemanske;Nicola A. Hanania;Phillip E. Korenblat

  • Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma.

    William Busse;Jonathan Corren;Bobby Quentin Lanier;Margaret McAlary

  • Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial

    Sally Wenzel;Mario Castro;Jonathan Corren;Jorge Maspero

  • Tezepelumab in Adults with Uncontrolled Asthma

    Jonathan Corren;Jane R. Parnes;Liangwei Wang;May Mo

  • Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma.

    Andrew Menzies-Gow;Jonathan Corren;Arnaud Bourdin;Geoffrey Chupp

  • Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials.

    Philippe Gevaert;Theodore A. Omachi;Jonathan Corren;Joaquim Mullol

  • Efficacy of soluble IL-4 receptor for the treatment of adults with asthma

    Larry C. Borish;Harold S. Nelson;Jonathan Corren;George Bensch

  • Allergic rhinitis and asthma: How important is the link?

    Jonathan Corren

  • Phase 3 Study of Reslizumab in Patients With Poorly Controlled Asthma: Effects Across a Broad Range of Eosinophil Counts

    Jonathan Corren;Steven Weinstein;Lindsay Janka;James Zangrilli

  • Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies

    Nicola A Hanania;Michael Noonan;Jonathan Corren;Phillip Korenblat

  • A Randomized, Controlled, Phase 2 Study of AMG 317, an IL-4Rα Antagonist, in Patients with Asthma

    Jonathan Corren;William Busse;Eli O. Meltzer;Lyndon Mansfield

  • Conjunctivitis in dupilumab clinical trials.

    B. Akinlade;E. Guttman-Yassky;M. de Bruin-Weller;E. L. Simpson

  • Nasal beclomethasone prevents the seasonal increase in bronchial responsiveness in patients with allergic rhinitis and asthma.

    Jonathan Corren;Allen D. Adinoff;Andrea D. Buchmeier;Charles G. Irvin

  • Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma

    Ioana Agache;Jessica Beltran;Cezmi Akdis;Mubeccel Akdis

  • Changes in bronchial responsiveness following nasal provocation with allergen

    Jonathan Corren;Allen D. Adinoff;Charles G. Irvin

  • Incidence and Characteristics of Angioedema Associated With Enalapril

    John B. Kostis;Harold J. Kim;James Rusnak;Thomas Casale

  • Rhinitis therapy and the prevention of hospital care for asthma: a case-control study

    Jonathan Corren;Beatrice E. Manning;Stephen F. Thompson;Sean Hennessy

  • Review of Alleged Reaction to Monosodium Glutamate and Outcome of a Multicenter Double-Blind Placebo-Controlled Study

    Raif S. Geha;Alexa Beiser;Clement Ren;Roy Patterson

  • Safety and tolerability of omalizumab

    J. Corren;T. B. Casale;B. Lanier;R. Buhl

  • Allergy, rhinitis, other respiratory diseases Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma

    William Busse;Jonathan Corren;Bobby Quentin Lanier;Margaret McAlary

Frequent Co-Authors

Thomas B. Casale
Thomas B. Casale University of South Florida
Mario Castro
Mario Castro Washington University in St. Louis
Neil M.H. Graham
Neil M.H. Graham Regeneron (United States)
Nicola A. Hanania
Nicola A. Hanania Baylor College of Medicine
Ian D. Pavord
Ian D. Pavord University of Oxford
Claus Bachert
Claus Bachert Karolinska Institute
William W. Busse
William W. Busse University of Wisconsin–Madison
Gianluca Pirozzi
Gianluca Pirozzi Sanofi (France)
Philippe Gevaert
Philippe Gevaert Ghent University
Reynold A. Panettieri
Reynold A. Panettieri Rutgers, The State University of New Jersey

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in Immunology often intersects with various healthcare fields, offering diverse online degree options and certifications to enhance your expertise. For those considering a nursing focus within immunological studies, exploring the cheapest pmhnp programs online can provide an affordable pathway to specialize as a psychiatric mental health nurse practitioner.

Many professionals advance their credentials by pursuing a Doctor of Nursing Practice, and understanding the doctor of nursing practice salary by state helps in evaluating potential financial outcomes post-graduation. Additionally, transitioning from family-focused nursing roles to more acute care settings is common — getting an acute care certification for fnp can boost your qualifications and open new clinical opportunities.

For those eager to accelerate their nursing practitioner training, enrolling in the accelerated fnp program provides a faster route to obtaining essential skills needed in immunology-related healthcare roles.

Best Scientists Citing Jonathan Corren

Trending Scientists